Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen

By Attallah A.M.   Attia H.   Ismail H.   Yones E.   El-Nashar E.M.   Abd El-Kader K.   Tabll A.   Saad A.   Sultan A.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2786-2791

Elsevier

Access to resources Recommend Favorite

Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase

By Ivanoff N.   Phillips N.   Schacht A.-M.   Heydari C.   Capron A.   Riveau G.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1123-1131

Elsevier

Access to resources Recommend Favorite

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH

By Argiro L.L.   Kohlstadt S.S.   Henri S.S.   Dessein H.H.   Matabiau V.V.   Paris P.P.   Bourgois A.A.   Dessein A.J.A.J.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2039-2048

Elsevier

Access to resources Recommend Favorite

IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN- and TNF- dependent pathway

By Fonseca C.T.   Brito C.F.A.   Alves J.B.   Oliveira S.C.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 503-510

Elsevier

Access to resources Recommend Favorite

Characterization of Schistosoma mansoni 44.7/56.8 kDa egg antigens recognized by human monoclonal antibodies which induce protection against experimental infection and proliferation of peripheral blood mononuclear cells from schistosomiasis patients

By Hirsch C.   Almeida C.A.   Doughty B.L.   Goes A.M.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 948-954

Elsevier

Access to resources Recommend Favorite